Anthony is Professor of Microbiology and Deputy Executive Dean of Life & Health Sciences at Aston University in Birmingham, UK. Dr Worthington is Reader in Clinical Microbiology and a HCPC Registered Biomedical Scientist. All work undertaken by Microbiology Consulting is independent of Aston University unless by prior arrangement and no reference may be made to Professor Hilton's or Dr Worthington's association with Aston University unless by express permission.
Professor Anthony C Hilton
B.Sc., PhD., Pg. Cert. LTHE, PFHEA, NTF, CBiol, FRSB, FIBMS
Visit Anthony's website at Aston University
Following a PhD in microbiology from the University of Birmingham, Anthony remained at the University as a lecturer in the Institute of Public & Environmental Health for five years before moving to Aston University in 2000. At Aston, Anthony has continued to pursue his research interest in the molecular epidemiology of foodborne pathogens (Salmonella, Campylobacter and E. coli in particular) and other important clinical bacteria including MRSA and Clostridium difficile. He was appointed as Senior Lecturer and Director of Biology / Biomedical Sciences in 2005 and promoted to Reader and Head of Department in 2009. He has served as the Honorary General Secretary of the Society for Applied Microbiology and held several journal editorial positions. Professor Hilton is Fellow of the Society for Biology and the Institute of Biomedical Science. Through his work with the media he is a regular contributor to print and broadcast articles in the field of popular microbiology and has published his research across a variety of microbiological topics.
Dr Tony Worthington
PhD, CSi, FIBMS
Visit Tony's website at Aston University
Tony is a HCPC registered (BS34219) Reader in Clinical Microbiology at Aston University. In addition, he is a Chartered Scientist (CSci), Fellow of the Institute of Biomedical Science (FIBMS), Member of the Society of Biology (MSB) and a Fellow of the Higher Education Academy (FHEA). He undertook his PhD in Medical Microbiology focusing upon the serological response to short chain exocellular lipoteichoic acid produced by Staphylococcus epidermidis. Following his PhD, he continued to undertake clinical research into healthcare related infections and prevention including: intravascular device related sepsis, skin antisepsis, MRSA and Clostridium difficile. Since 2004, he has been awarded in excess of £800,000 of research funding from sources including the Engineering and Physical Sciences Research Council (EPSRC), Knowledge Transfer Partnerships and the Department of Health to explore novel strategies in infection control including: improved skin antisepsis and hard surface disinfection, development of a novel hand hygiene antimicrobial and the development of germination-biocide formulation for elimination of Clostridium difficile spores and other clinically relevant microorganisms from within the clinical setting. In addition to liaising closely with academic colleagues in the fields of microbiology, pharmaceutics and drug delivery, he has well-established research collaborations with both the healthcare industry and the NHS. He has published papers within the field of clinical microbiology and the research findings have been presented at international scientific proceedings eg. ECCMID. He has over 50 peer reviewed publications, and contributed chapters to fundamental microbiology text books as co-author on the 4th edition of Lecture Notes on Medical Microbiology and Infection (2007).
Dr Jonathan Cox
BSc (Hons), PhD, MRSB, FHEA, FIBMS
Dr Jonathan Cox is a specialist in antimicrobial agents and has extensive experience in the design and implementation of experimental trials to test their efficacy. He holds a PhD in Molecular Microbiology and Drug Discovery, is a Fellow of the Institute of Biomedical Science and Fellow of the Higher Education Academy. Jonathan has worked extensively in both industrial and academic antimicrobial research and development. In addition to experimental consultancy, as a Lecturer in Microbiology, Jonathan also offers seminars, training sessions and consultancy on aseptic working practices, infection management and control, antibiotics and antibiotic resistance. His research focuses on the Mycobacteria sp. of pathogenic bacteria, with the aim of discovering new antimicrobial and new combinations of antibiotics that can be used clinically to treat mycobacterial infection. From this research, Jonathan has published extensively in high impact journals (Nature Microbiology, Nature Communications etc.), but he is also committed to public engagement in science, engaging with the broadcast media and publishing articles in the press.